Surgery Partners (SGRY) Net Cash Flow (2014 - 2026)

Surgery Partners' Net Cash Flow history runs 13 years deep, the most recent figure standing at -$57.6 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 43.28% year-over-year to -$57.6 million; the TTM figure through Mar 2026 stood at -$47.0 million (down 206.58% YoY), while the FY2025 annual figure was -$29.6 million, down 140.22% from the prior year.
• Net Cash Flow came in at -$57.6 million for Q1 2026 at Surgery Partners, down from $36.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $128.1 million in Q4 2022 to a low of -$151.5 million in Q2 2022.
• A 5-year average of -$12.2 million and a median of -$11.0 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 218.95% in 2024 and slumped 662.65% in 2025, its largest moves.
• Surgery Partners' Net Cash Flow stood at $128.1 million in 2022, then sank by 131.3% to -$40.1 million in 2023, then soared by 218.95% to $47.7 million in 2024, then retreated by 23.48% to $36.5 million in 2025, then plunged by 257.81% to -$57.6 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$57.6 million, $36.5 million, and -$46.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison